NeoGenomics, Inc. - stock earnings
NEO Upcoming estimated earnings
| Date | Actual / Estimated EPS | Low Revenue | Actual / Estimated Revenue | High Revenue |
|---|---|---|---|---|
| April 30, 2024 AfterMarket | -0.02 / -0.05 | - | 156.2 million / 151.4 million | - |
NEO Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q4 | -14.3 million USD | 155.6 million USD |
| 2023Q3 | -18.5 million USD | 152.0 million USD |
| 2023Q2 | -24.3 million USD | 146.9 million USD |
| 2023Q1 | -30.8 million USD | 137.2 million USD |
| 2022Q4 | -22.7 million USD | 138.7 million USD |
| 2022Q3 | -36.9 million USD | 128.8 million USD |
| 2022Q2 | -35.3 million USD | 125.1 million USD |
| 2022Q1 | -49.4 million USD | 117.2 million USD |
| 2021Q4 | -41.8 million USD | 125.7 million USD |
| 2021Q3 | -20.3 million USD | 121.3 million USD |
| 2021Q2 | 75.9 million USD | 121.7 million USD |
| 2021Q1 | -22.1 million USD | 115.5 million USD |
| 2020Q4 | 15.4 million USD | 126.0 million USD |
| 2020Q3 | 2.6 million USD | 125.4 million USD |
| 2020Q2 | -6.8 million USD | 87.0 million USD |
| 2020Q1 | -7.0 million USD | 106.0 million USD |
| 2019Q4 | 6.3 million USD | 106.9 million USD |
| 2019Q3 | 2.1 million USD | 104.7 million USD |
| 2019Q2 | 2.0 million USD | 101.7 million USD |
| 2019Q1 | -2.4 million USD | 95.6 million USD |
| 2018Q4 | 353000 USD | 76.5 million USD |
| 2018Q3 | 2.0 million USD | 69.1 million USD |
| 2018Q2 | -380000 USD | 67.7 million USD |
| 2018Q1 | 644000 USD | 63.4 million USD |
| 2017Q4 | 5.0 million USD | 67.8 million USD |
| 2017Q3 | -5.1 million USD | 63.1 million USD |
| 2017Q2 | -43000 USD | 66.1 million USD |
| 2017Q1 | -654000 USD | 61.7 million USD |
| 2016Q4 | -6.2 million USD | 60.5 million USD |
| 2016Q3 | -67000 USD | 60.8 million USD |
| 2016Q2 | 413000 USD | 63.1 million USD |
| 2016Q1 | 155000 USD | 59.7 million USD |
| 2015Q4 | -1.5 million USD | 27.3 million USD |
| 2015Q3 | -125000 USD | 25.1 million USD |
| 2015Q2 | -176000 USD | 24.4 million USD |
| 2015Q1 | -761000 USD | 23.0 million USD |
| 2014Q4 | 1.0 million USD | 25.0 million USD |
| 2014Q3 | -291000 USD | 23.2 million USD |
| 2014Q2 | 274000 USD | 20.7 million USD |
| 2014Q1 | 102000 USD | 18.2 million USD |
| 2013Q4 | 857000 USD | 18.3 million USD |
| 2013Q3 | 900000 USD | 16.9 million USD |
| 2013Q2 | 273000 USD | 15.6 million USD |
| 2013Q1 | 3000 USD | 15.7 million USD |
| 2012Q4 | -113000 USD | 14.9 million USD |
| 2012Q3 | -975000 USD | 14.2 million USD |
| 2012Q2 | 551000 USD | 15.6 million USD |
| 2012Q1 | 603000 USD | 15.2 million USD |
| 2011Q4 | 152000 USD | 12.9 million USD |
| 2011Q3 | -143000 USD | 11.3 million USD |
| 2011Q2 | -293000 USD | 10.5 million USD |
| 2011Q1 | -893000 USD | 8.8 million USD |
| 2010Q4 | -377000 USD | 8.8 million USD |
| 2010Q3 | -1.2 million USD | 8.7 million USD |
| 2010Q2 | -978000 USD | 8.5 million USD |
| 2010Q1 | -750000 USD | 8.4 million USD |
| 2009Q4 | -1.5 million USD | 7.8 million USD |
| 2009Q3 | -755305 USD | 7.3 million USD |
| 2009Q2 | 8060 USD | 7.5 million USD |
| 2009Q1 | -994376 USD | 5.9 million USD |
| 2008Q4 | -994376 USD | 5.9 million USD |
| 2008Q3 | -195125 USD | 5.1 million USD |
| 2008Q2 | 72277 USD | 4.9 million USD |
| 2008Q1 | -973503 USD | 2.3 million USD |
| 2007Q4 | -1.6 million USD | 3.8 million USD |
| 2007Q3 | -1.6 million USD | 3.8 million USD |
| 2007Q2 | -591263 USD | 3.1 million USD |
| 2007Q1 | -429245 USD | 1.8 million USD |
| 2006Q4 | -429245 USD | 1.8 million USD |
| 2006Q3 | 31895 USD | 1.6 million USD |
| 2006Q2 | 161255 USD | 1.8 million USD |
| 2006Q1 | -360692 USD | 750895 USD |
| 2005Q4 | -360692 USD | 750895 USD |
| 2005Q3 | -239937 USD | 559349 USD |
| 2005Q2 | -181358 USD | 344888 USD |
| 2005Q1 | -309776 USD | 135820 USD |
| 2004Q4 | -309776 USD | 135820 USD |
| 2004Q3 | -170856 USD | 121859 USD |
| 2004Q2 | -168745 USD | 121532 USD |
| 2004Q1 | -169609 USD | 178863 USD |
| 2003Q4 | -144048 USD | 136554 USD |
| 2003Q3 | -138114 USD | 90240 USD |
| 2003Q2 | -138796 USD | 73009 USD |
| 2003Q1 | 1.5 million USD | 57138 USD |
| 2002Q4 | 1.5 million USD | 57138 USD |
| 2002Q3 | -732198 USD | 27869 USD |
| 2002Q2 | -740247 USD | 8484 USD |
| 2002Q1 | -7.2 million USD | ? USD |
| 2001Q4 | -7.2 million USD | ? USD |
| 2001Q3 | -289344 USD | ? USD |
| 2001Q2 | -214598 USD | 1 USD |
| 2001Q1 | -236410 USD | 1 USD |
| 2000Q4 | -236410 USD | 252000 USD |
| 2000Q3 | -351264 USD | 1 USD |
| 2000Q2 | -216979 USD | 126238 USD |
| 2000Q1 | -165627 USD | 126165 USD |
| 1999Q2 | -99048 USD | ? USD |
| 1999Q1 | -99048 USD | ? USD |
NEO Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -88.0 million USD | 591.6 million USD |
| 2022 | -144.3 million USD | 509.7 million USD |
| 2021 | -8.3 million USD | 484.3 million USD |
| 2020 | 4.2 million USD | 444.4 million USD |
| 2019 | 8.0 million USD | 408.8 million USD |
| 2018 | 2.6 million USD | 276.7 million USD |
| 2017 | -846000 USD | 258.6 million USD |
| 2016 | -5.7 million USD | 244.1 million USD |
| 2015 | -2.5 million USD | 99.8 million USD |
| 2014 | 1.1 million USD | 87.1 million USD |
| 2013 | 2.0 million USD | 66.5 million USD |
| 2012 | 65000 USD | 59.9 million USD |
| 2011 | -1.2 million USD | 43.5 million USD |
| 2010 | -3.3 million USD | 34.4 million USD |
| 2009 | -2.2 million USD | 29.5 million USD |
| 2008 | -1.4 million USD | 20.0 million USD |
| 2007 | -3.4 million USD | 11.5 million USD |
| 2006 | -129661 USD | 6.5 million USD |
| 2005 | -997160 USD | 1.9 million USD |
| 2004 | -818985 USD | 558074 USD |
| 2003 | -535763 USD | 369972 USD |
| 2002 | -590524 USD | 93491 USD |
| 2001 | -8.1 million USD | 1000 USD |
| 2000 | -970280 USD | 252403 USD |
NEO
Price: $14.72
52 week price:
Payout Ratio Range:
Earnings Per Share: -0.70 USD
P/E Ratio: -18.65
Exchange: NCM
Sector: Healthcare
Industry: Diagnostics & Research
Volume: 437800
Ebitda: 2.2 millionMarket Capitalization: 1.9 billion